SCHEMBL330011

SCHEMBL330011

CC(=O)NC(C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL330009 1.00
SCHEMBL330308 1.00
Ammonia Solution, Strong SCHEMBL28164671 0.97 ALDH1A1 (0.48)
SCHEMBL29078950 0.97 ALDH1A1 (0.48)
SCHEMBL11433892 0.97 ALDH1A1 (0.48)
Ammonia Solution, Strong SCHEMBL28164672 0.97 ALDH1A1 (0.48)
Hydrochloric Acid SCHEMBL28235390 0.97 ALDH1A1 (0.48)
SCHEMBL29078952 0.97 ALDH1A1 (0.48)
SCHEMBL8968093 0.92 ALDH1A1 (0.45)
SCHEMBL3373326 0.90 MME (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1840 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO claimed
EP-4720103-A2 THERAPEUTIC USES OF ADIPOSE-SECRETED SIGNALING PROTEIN (ADISSP) University Of Massachusetts (US) 2026-04-08 EP claimed
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-24 US claimed
US-20260009800-A1 METHODS OF DIAGNOSIS AND GUIDING TREATMENT OF VULVOVAGINAL SYMPTOMS AND FEMALE SEXUAL DYSFUNCTION UNIV ARIZONA (US) 2026-01-08 US claimed
US-20250320265-A1 BROWN FAT-SELECTIVE ADIPOKINES UNIV MASSACHUSETTS (US) 2025-10-16 US claimed
US-12370173-B2 Pet food compositions that modulate vitamin D and bone mineral content in a companion animal SOCIETE DES PRODUITS NESTLE S.A. (CH) 2025-07-29 US claimed
US-12371462-B2 Brown fat-selective adipokines UNIVERSITY OF MASSACHUSETTS (US) 2025-07-29 US claimed
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO claimed
CN-119701018-A Activated hydrophilic near infrared fluorescent probe, liposome fluorescent probe, cell membrane fluorescent probe, preparation method and application thereof 嘉庚创新实验室 2025-03-28 CN claimed
EP-3555615-B9 MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES METABOLON INC (US) 2025-03-19 EP claimed
EP-0896057-A2 D-aminoacylase DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) 1999-02-10 EP claimed
EP-0864578-A2 Platinum (IV) complex and pharmaceutical composition comprising the same SS PHARMACEUTICAL CO., LTD. (JP) 1998-09-16 EP claimed
US-5672337-A TOPICAL APPLICATION TO SKIN, HAIR L'OREAL (FR) 1997-09-30 US claimed
EP-0723586-A1 ENZYME AND ITS USE IN PREPARING (S)-PIPECOLIC ACID Chiroscience Limited (GB) 1996-07-31 EP claimed
WO-1995026744-A1 TUMOR NECROSIS FACTOR INHIBITORS CENTOCOR, INC. (US) 1995-10-12 WO claimed
EP-0451760-B1 Nitrato alkanoic acid derivatives and method for their production SANOL ARZNEI SCHWARZ GMBH (DE) 1995-09-13 EP claimed
WO-1995010604-A1 ENZYME AND ITS USE IN PREPARING (S)-PIPECOLIC ACID CHIROSCIENCE LIMITED (GB) 1995-04-20 WO claimed
US-5284872-A Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof SCHWARZ PHARMA AG (DE) 1994-02-08 US claimed
EP-0558961-A2 Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them BEHRINGWERKE Aktiengesellschaft (DE) 1993-09-08 EP claimed
US-4405638-A ANTITUSSIVE AGENTS; ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A (IT) 1983-09-20 US claimed